Chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients of any gender, aged between 40 and 85 years old; (2) Accord with that diagnostic criteria for chronic obstructive pulmonary disease (COPD) and have a predicted FEV1 value between 30% and 80%; (3) Accord with that diagnostic criteria for traditional Chinese medicine differentiation; (4) Conscious and hemodynamically stable; (5) Willing to participate in this study and sign an informed consent file.
Exclusion criteria
Exclusion criteria: (1) Lung diseases with known causes or specific pathological presentations that result in airflow obstruction, such as cystic fibrosis, diffuse panbronchiolitis, etc; (2) Patients with concomitant lung diseases such as pulmonary tuberculosis, malignant lung tumors, etc; (3) Patients with respiratory failure, severe cardiac, hepatic, or renal insufficiency; (4) Patients with a history of hypersensitivity or allergic reactions to the investigational drugs in this trial;(5) Patients in the acute exacerbation phase of chronic obstructive pulmonary disease (COPD);(6) Patients currently participating in other clinical trials that may affect the evaluation of the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1%; | — |
Secondary
| Measure | Time frame |
|---|---|
| diaphragmatic excursion;frequency of acute exacerbations;SF36 Quality of Life Scale;TCM symptom score ; | — |
Countries
China
Contacts
Traditional Chinese Medicine Hospital Fengxian Shanghai